Nigel Crockett is the current Chief Business Officer at Bicycle Therapeutics. Nigel has held various business development positions at various companies over the years, including NodThera Limited, Crescendo Biologics Limited, Psioxus Therapeutics, Medivir AB, Iconix Biosciences, Microbiotica Ltd, Trig1, and Heptares. Nigel also has experience as a managing partner at Tukan Partners Ltd.
Nigel Crockett was educated at Cambridge University, where they received their PhD. Nigel also holds a Bsc from The University of Manchester.
Nigel Crockett reports to Kevin Lee, Chief Executive Officer. They are on a team with Zafar Qadir - General Counsel, Dominic Smethurst - Chief Medical Officer, and Michael Skynner - Chief Operating Officer.
September, 2019 - present